Mitral annular calcification predicts mortality and coronary artery disease in end stage renal disease

Rajan Sharma1, Denis Pellerin, David C Gaze

  • 1Department of Cardiology, St George's Hospital, London, United Kingdom. rajdoc.Sharma@tiscali.co.uk

Atherosclerosis
|May 2, 2006
PubMed

Insights

Mitral annular calcification (MAC) predicts mortality and cardiac disease in renal transplant candidates. Patients with MAC showed higher mortality, increased left ventricular size, and poorer systolic function.

Area of Science:

  • Nephrology
  • Cardiology
  • Medical Imaging

Background:

  • Mitral annular calcification (MAC) is a common finding in patients with end-stage renal disease (ESRD).
  • The prognostic significance of MAC in renal transplant candidates is not well-established.

Purpose of the Study:

  • To determine if mitral annular calcification (MAC) predicts mortality and cardiac disease in patients awaiting renal transplantation.

Main Methods:

  • 140 renal transplant candidates underwent echocardiography and coronary angiography.
  • Significant coronary artery disease (CAD) was defined as >70% stenosis in any major coronary artery.

Main Results:

  • MAC was present in 40% of patients and associated with higher mortality (p=0.04).
  • MAC patients were older, had larger left ventricular dimensions, reduced systolic function, and higher LV filling pressures.
  • Significant CAD was the only independent predictor of MAC (OR 12, p=0.001).
  • Higher levels of plasma calcium, phosphate, troponin T, and NT-proBNP were observed in patients with MAC.

Conclusions:

  • Mitral annular calcification (MAC) is a significant predictor of mortality and coronary artery disease in ESRD patients.
  • MAC is linked to adverse cardiac structural and functional changes, including increased left ventricular cavity size, impaired systolic function, and elevated filling pressures.
Abstract

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...